Walleye Capital
IMMU

Walleye Capital’s Immunomedics Inc IMMU Stock Holding History

Walleye Capital’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11,200
Closed -$215K – 2206
2019
Q1 		$215K Buy
+11,200
New +$181K 0.04% 750

Walleye Capital's IMMU Position: Q4 2020 in Review

Walleye Capital sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 51,272 shares — an estimated $4.36M sold.

Walleye Capital first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $4.36M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Walleye Capital reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Walleye Capital sold 51,272 Immunomedics Inc shares in Q4 2020, an estimated $4.36M.
  • Walleye Capital first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
  • Walleye Capital's Immunomedics Inc position peaked at $4.36M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Walleye Capital's 13F filing for Q4 2020, filed 16 Feb 2021.